BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao F, Long Y, Ji H, Jiang D, Lei P, Lan X. Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring. Theranostics 2021;11:6800-17. [PMID: 34093854 DOI: 10.7150/thno.56989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Molchanov OE, Maystrenko DN, Stanzhevskiy AA. Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya 2022;12:425-443. [DOI: 10.30895/1991-2919-2022-12-4-425-443] [Reference Citation Analysis]
2 Liu Z, Zhou Z, Dang Q, Xu H, Lv J, Li H, Han X. Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. Theranostics 2022;12:6273-90. [PMID: 36168626 DOI: 10.7150/thno.76854] [Reference Citation Analysis]
3 Long Y, Lv X, Song X, Shao F, Ji H, Zhang Y, Qiao P, Liu Q, Xia X, Lei P, Gai Y, Lan X. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05886-7] [Reference Citation Analysis]
4 Van Hoeck J, Vanhove C, De Smedt SC, Raemdonck K. Non-invasive cell-tracking methods for adoptive T cell therapies. Drug Discov Today 2021:S1359-6446(21)00449-9. [PMID: 34718210 DOI: 10.1016/j.drudis.2021.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Al Tabaa Y, Bailly C, Kanoun S. FDG-PET/CT in Lymphoma: Where Do We Go Now? Cancers (Basel) 2021;13:5222. [PMID: 34680370 DOI: 10.3390/cancers13205222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]